Outset Medical, Inc.
OM- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001484612
In the last 90 days, Outset Medical, Inc. insiders filed 0 open-market purchases and 3 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $59.8M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Outset Medical, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- −1 vs. Q3 2025
- Shares held
- 15.6M
- −2.27M (−12.7%) vs. Q3 2025
- Total value
- $58.0M
- −$193.7M (−77.0%) vs. Q3 2025
- New holders
- 20
- 34 more added
- Sold out
- 21
- 26 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 92 | $59.8M |
| Q1 2026 | 99 | $57.1M |
| Q4 2025 | 100 | $58.0M |
| Q3 2025 | 101 | $251.7M |
| Q2 2025 | 94 | $352.5M |
| Q1 2025 | 61 | $162.6M |
| Q4 2024 | 74 | $23.4M |
| Q3 2024 | 80 | $17.6M |
| Q2 2024 | 122 | $187.0M |
| Q1 2024 | 114 | $112.1M |
| Q4 2023 | 140 | $286.8M |
| Q3 2023 | 153 | $583.9M |
| Q2 2023 | 155 | $1.16B |
| Q1 2023 | 163 | $957.2M |
| Q4 2022 | 153 | $1.27B |
| Q3 2022 | 139 | $759.5M |
| Q2 2022 | 152 | $721.2M |
| Q1 2022 | 153 | $2.33B |
| Q4 2021 | 157 | $2.24B |
| Q3 2021 | 143 | $2.51B |
| Q2 2021 | 129 | $2.31B |
| Q1 2021 | 111 | $2.09B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Outset Medical, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Durable Capital Partners LP | 0 | $0 | 0.00% | −1,023,706−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −631,663−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −454,512−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −146,598−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −116,291−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −114,800−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −58,972−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −54,005−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −44,869−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,796−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −13,343−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −11,074−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,997−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −10,308−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,245−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −1,239−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −356−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −72−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Kilter Group LLC | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Missouri Trust & Investment Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |